N4P.L
N4 Pharma Plc, a specialist pharmaceutical company, develops novel silica nanoparticle delivery system for pharmaceutical and biotechnology companies in the United Kingdom. It develops Nuvec, a non-viral adjuvant delivery system for vaccines and cancer treatments. N4 Pharma Plc was incorporated in 1979 and is based in London, the United Kingdom.
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
1988-07-01
Stock Exchange
LSE
Ticker
N4P.L
According to N4 Pharma Plc’s latest financial reports and current stock price. The company's current Current Ratio is 23.55. This represents a change of 39.82% compared to the average of 16.84 of the last 4 quarters.
The mean historical Current Ratio of N4 Pharma Plc over the last ten years is 15.36. The current 23.55 Current Ratio has changed 15.23% with respect to the historical average. Over the past ten years (40 quarters), N4P.L's Current Ratio was at its highest in in the December 2015 quarter at 35.76. The Current Ratio was at its lowest in in the June 2006 quarter at 0.17.
Average
15.36
Median
12.36
Minimum
5.63
Maximum
35.76
Discovering the peaks and valleys of N4 Pharma Plc Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 2.24%
Maximum Annual Current Ratio = 35.76
Minimum Annual Increase = -78.18%
Minimum Annual Current Ratio = 5.63
| Year | Current Ratio | Change |
|---|---|---|
| 2024 | 6.24 | -58.01% |
| 2023 | 14.86 | -46.58% |
| 2022 | 27.81 | 152.56% |
| 2021 | 11.01 | -51.34% |
| 2020 | 22.63 | 65.07% |
| 2019 | 13.71 | 143.59% |
| 2018 | 5.63 | -30.86% |
| 2017 | 8.14 | 4.30% |
| 2016 | 7.81 | -78.18% |
| 2015 | 35.76 | 2.24% |
The current Current Ratio of N4 Pharma Plc (N4P.L) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
16.30
5-year avg
16.51
10-year avg
15.36
N4 Pharma Plc’s Current Ratio is greater than Chill Brands Group PLC (0.80), greater than Proteome Sciences plc (0.11), greater than Theracryf Plc (3.11), greater than CRISM Therapeutics Corporation (3.65), greater than Tissue Regenix Group plc (2.88), greater than MyHealthChecked PLC (2.54), greater than Genedrive Plc (4.13), greater than Feedback plc (10.49), greater than Surgical Innovations Group plc (2.11), greater than Oxford BioDynamics Plc (2.59),
| Company | Current Ratio | Market cap |
|---|---|---|
| 0.80 | N/A | |
| 0.11 | N/A | |
| 3.11 | N/A | |
| 3.65 | N/A | |
| 2.88 | N/A | |
| 2.54 | N/A | |
| 4.13 | N/A | |
| 10.49 | N/A | |
| 2.11 | N/A | |
| 2.59 | N/A |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like N4 Pharma Plc using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like N4 Pharma Plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is N4 Pharma Plc's Current Ratio?
How is the Current Ratio calculated for N4 Pharma Plc (N4P.L)?
What is the highest Current Ratio for N4 Pharma Plc (N4P.L)?
What is the 3-year average Current Ratio for N4 Pharma Plc (N4P.L)?
What is the 5-year average Current Ratio for N4 Pharma Plc (N4P.L)?
How does the current Current Ratio for N4 Pharma Plc (N4P.L) compare to its historical average?